Pacira BioSciences' Change in Accured Expenses fell 3267.77% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.0 million, marking a year-over-year decrease of 14783.65%. This contributed to the annual value of $11.7 million for FY2024, which is 15317.85% up from last year.
According to the latest figures from Q3 2025, Pacira BioSciences' Change in Accured Expenses is $7.5 million, which was down 3267.77% from -$19.4 million recorded in Q2 2025.
In the past 5 years, Pacira BioSciences' Change in Accured Expenses ranged from a high of $22.5 million in Q4 2021 and a low of -$25.1 million during Q1 2023
Moreover, its 5-year median value for Change in Accured Expenses was -$113000.0 (2021), whereas its average is -$1.7 million.
In the last 5 years, Pacira BioSciences' Change in Accured Expenses tumbled by 864070.8% in 2022 and then skyrocketed by 20205.66% in 2023.
Pacira BioSciences' Change in Accured Expenses (Quarter) stood at $22.5 million in 2021, then tumbled by 83.53% to $3.7 million in 2022, then rose by 11.18% to $4.1 million in 2023, then crashed by 120.06% to -$826000.0 in 2024, then skyrocketed by 1011.62% to $7.5 million in 2025.
Its Change in Accured Expenses was $7.5 million in Q3 2025, compared to -$19.4 million in Q2 2025 and $4.7 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value